BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 28719256)

  • 1. Therapeutic Dilemma of Refractory Erythema Nodosum Leprosum.
    Zhu J; Yang D; Shi C; Jing Z
    Am J Trop Med Hyg; 2017 Jun; 96(6):1362-1364. PubMed ID: 28719256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases.
    Narang T; Kaushik A; Dogra S
    Br J Dermatol; 2020 Apr; 182(4):1034-1037. PubMed ID: 31218666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous Erythema Nodosum Leprosum as the First Manifestation of Multibacillary Leprosy: A Rare Phenomenon.
    Bakshi N; Rao S; Batra R
    Am J Dermatopathol; 2017 Nov; 39(11):857-859. PubMed ID: 28763338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences with Thalidomide for Erythema Nodosum Leprosum– a retrospective study.
    Darlong J; Govindharaj P; Charles DE; Menzies A; Mani S
    Lepr Rev; 2016 Jun; 87(2):211-20. PubMed ID: 30212168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B; Pallapati MS; Tarwater P; Srikantam A
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients.
    Hossain D
    Lepr Rev; 2013 Mar; 84(1):105-12. PubMed ID: 23741889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.
    Gupta SK; Kumari S
    An Bras Dermatol; 2022; 97(1):49-53. PubMed ID: 34848113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
    Verma KK; Srivastava P; Minz A; Verma K
    Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide.
    Vetrichevvel TP; Pise GA; Thappa DM
    Lepr Rev; 2008 Jun; 79(2):193-5. PubMed ID: 18711941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
    Pal D
    Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A real-world study of low-dose thalidomide in severe erythema nodosum leprosum highlighting its mechanistic rationale in a resource-constrained target population.
    Bathula S; Sardana K; Mathachan SR; Khurana A; Ahuja A; Paliwal P
    Int J Dermatol; 2023 Jan; 62(1):48-55. PubMed ID: 35924464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept.
    Chowdhry S; Shukla A; D'souza P; Dhali T; Jaiswal P
    Int J Mycobacteriol; 2016 Jun; 5(2):223-5. PubMed ID: 27242236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept.
    Ramien ML; Wong A; Keystone JS
    Clin Infect Dis; 2011 Mar; 52(5):e133-5. PubMed ID: 21292656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
    Rattan R; Shanker V; Tegta GR; Verma GK
    Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
    Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
    Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the retreatment of patients with multibacillary leprosy and episodes of erythema nodosum leprosum and/or persistent neuritis: a single-center experience.
    Lastória JC; Almeida TSC; Putinatti MSMA; Padovani CR
    An Bras Dermatol; 2018 Mar; 93(2):181-184. PubMed ID: 29723371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.